TATA Health International Holdings Limited reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was HKD 63.52 million compared to HKD 73.12 million a year ago. Net income was HKD 20.17 million compared to net loss of HKD 27.08 million a year ago.

Basic earnings per share from continuing operations was HKD 0.083 compared to basic loss per share from continuing operations of HKD 0.123 a year ago.